Increased glycine contributes to synaptic dysfunction and early mortality in Nprl2 seizure model.
Increased glycine contributes to synaptic dysfunction and early mortality in Nprl2 seizure model.
复制标题
DOI:
10.1016/j.isci.2022.104334
复制
发表时间:
2022-05-20
期刊:
影响因子:
5.8
通讯作者:
Tsai, Peter T.
中科院分区:
文献类型:
--
作者:
Dentel, Brianne;Angeles-Perez, Lidiette;Ren, Chongyu;Jakkamsetti, Vikram;Holley, Andrew J.;Caballero, Daniel;Oh, Emily;Gibson, Jay;Pascual, Juan M.;Huber, Kimberly M.;Tu, Benjamin P.;Tsai, Peter T.
Targeted therapies for epilepsies associated with the mTORC1 signaling negative regulator GATOR1 are lacking. NPRL2 is a subunit of the GATOR1 complex and mutations in GATOR1 subunits, including NPRL2, are associated with epilepsy. To delineate the mechanisms underlying NPRL2-related epilepsies, we created a mouse (Mus musculus) model with neocortical loss of Nprl2. Mutant mice have increased mTORC1 signaling and exhibit spontaneous seizures. They also display abnormal synaptic function characterized by increased evoked and spontaneous EPSC and decreased evoked and spontaneous IPSC frequencies, respectively. Proteomic and metabolomics studies of Nprl2 mutants revealed alterations in known epilepsy-implicated proteins and metabolic pathways, including increases in the neurotransmitter, glycine. Furthermore, glycine actions on the NMDA receptor contribute to the electrophysiological and survival phenotypes of these mice. Taken together, in this neuronal Nprl2 model, we delineate underlying molecular, metabolic, and electrophysiological mechanisms contributing to mTORC1-related epilepsy, providing potential therapeutic targets for epilepsy. Neocortical loss of Nprl2 leads to mTORC1-dependent seizures and decreased survival Conditional Nprl2 mutants show increased synaptic excitation and decreased inhibition Neurotransmitter glycine is increased in Nprl2 mutant neocortex Glycine actions at NMDA receptor contribute to synaptic and survival phenotypes Neuroscience; Molecular neuroscience; Omics; Metabolomics
登录
查看更多内容
影响因子:
8.8
作者:
Dutchak PA;Laxman S;Estill SJ;Wang C;Wang Y;Wang Y;Bulut GB;Gao J;Huang LJ;Tu BP
通讯作者:
Tu BP
影响因子:
14.8
作者:
Chen J;Sutter BM;Shi L;Tu BP
通讯作者:
Tu BP
DOI:
10.1038/s41436-018-0060-2
发表时间:
2019-03
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
Baldassari S;Picard F;Verbeek NE;van Kempen M;Brilstra EH;Lesca G;Conti V;Guerrini R;Bisulli F;Licchetta L;Pippucci T;Tinuper P;Hirsch E;de Saint Martin A;Chelly J;Rudolf G;Chipaux M;Ferrand-Sorbets S;Dorfmüller G;Sisodiya S;Balestrini S;Schoeler N;Hernandez-Hernandez L;Krithika S;Oegema R;Hagebeuk E;Gunning B;Deckers C;Berghuis B;Wegner I;Niks E;Jansen FE;Braun K;de Jong D;Rubboli G;Talvik I;Sander V;Uldall P;Jacquemont ML;Nava C;Leguern E;Julia S;Gambardella A;d'Orsi G;Crichiutti G;Faivre L;Darmency V;Benova B;Krsek P;Biraben A;Lebre AS;Jennesson M;Sattar S;Marchal C;Nordli DR Jr;Lindstrom K;Striano P;Lomax LB;Kiss C;Bartolomei F;Lepine AF;Schoonjans AS;Stouffs K;Jansen A;Panagiotakaki E;Ricard-Mousnier B;Thevenon J;de Bellescize J;Catenoix H;Dorn T;Zenker M;Müller-Schlüter K;Brandt C;Krey I;Polster T;Wolff M;Balci M;Rostasy K;Achaz G;Zacher P;Becher T;Cloppenborg T;Yuskaitis CJ;Weckhuysen S;Poduri A;Lemke JR;Møller RS;Baulac S
通讯作者:
Baulac S
影响因子:
5.3
作者:
de Calbiac H;Dabacan A;Marsan E;Tostivint H;Devienne G;Ishida S;Leguern E;Baulac S;Muresan RC;Kabashi E;Ciura S
通讯作者:
Ciura S
影响因子:
6.1
作者:
De Fusco, Antonio;Cerullo, Maria Sabina;Benfenati, Fabio
通讯作者:
Benfenati, Fabio